Carbidopa inhibits aromatic-L-amino-acid decarboxylase (DDC), an enzyme important in the biosynthesis of L-tryptamine to 5-HT and in the biosynthesis of L-DOPA to Dopamine (DA). Along with carbidopa, other DDC inhibitors are benserazide (Ro-4-4602), difluromethyldopa, and a-methyldopa.

Used in tandem with levodopa (l-dopa, a dopamine precurser converted in the body to dopamine), it increases the plasma half-life of levodopa from 50 minutes to 1 1/2 hours.

Read more at Wikipedia.org

• [List your site here Free!]



	New formulation: Parcopa®, Schwarz Pharma: Carbidopa-levodopa Parkinson's tablet approved The orally-disintegrating tablet formulation of carbidopa-levodopa was approved for the treatment of symptoms of idiopathic ... From Geriatrics, 11/1/04

	Pharmaceutical: top 50 packages PHARMACEUTICAL From Food & Drug Packaging, 7/1/05

	3Q results reflect ups and downs of generics pharmaceutical industry NEW YORK -- Early November brought the good, the bad and the ugly for generic drug makers. As third quarter results came out, the top three generic drug makers demonstrated the power of me-too drug From Drug Store News, 11/22/04 by Michelle L. Kirsche

	RECOGNITION AND TREATMENT OF DEPRESSION IN LONG TERM CARE FACILITIES Depression in the elderly is a growing concern and is considered a serious public health problem because it is not a normal consequence of aging. Depression ... From Medicine and Health Rhode Island, 8/1/04 by Patry, Gail

	Oral L-dopa solution therapy of menstrual-related fluctuations in Parkinson's disease HORMONE REPLACEMENTTHERAPY Oral L-dopa solution therapy of menstrual-related fluctuations in Parkinson's disease. Garcia-Moreno JM, Paramo L, Chacon J. From International Journal of Pharmaceutical Compounding, 7/1/04 by Foy, Elizabeth

	Top 50 pharmaceutical packagers Top 50 Pharmaceutical Packagers RANK COMPANY 2003 REVENUES (IN $ MILLIONS) 1 PFIZER INC. From Food & Drug Packaging, 7/1/04

	Dementia with Lewy Bodies vs. Alzheimer's Disease First described in 1961, dementia with Lewy bodies is believed to account for up to 20 percent of dementia cases. The condition is characterized by a progressive decline in cognitive function assoc From American Family Physician, 6/1/04 by Anne Walling

	Maintenance ECT in the treatment of PD: therapy improves psychotic symptoms, physical function - The Psychiatric Consultant Parkinson's disease, a neurodegenerative disorder characterized by a loss of dopaminergic cells in the substantia nigra as well as other pigmented nuclei,1 ... From Geriatrics, 11/1/03 by Robert B. Shulman

Home

Contact

Resources

Exchange Links

ebay